Empery Asset Management »

Xilio Therapeutics shares owned by Empery Asset Management

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $757k 1.2M 0.64

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Immuneering Corp Class A Com (IMRX)
Empery Digital Com New (EMPD)
Imperial Pete Com New (IMPP)
Precision BioSciences Com New (DTIL)
Aduro Clean Technologies Com New (ADUR)
Tenaya Therapeutics (TNYA)
Critical Metals Corp Pubco Ord Shs (CRML)
Eos Energy Enterprises Com Cl A (EOSE)
Surrozen Com New (SRZN)
Talphera Com New (TLPH)
Kazia Therapeutics Sponsored Ads (KZIA)
Profound Med Corp Com New (PROF)
Robin Energy Ord Shs New (RBNE)
Super League Enterprise Com New (SLE)

View all positions for Empery Asset Management

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Frazier Life Sciences Management
Point72 Asset Management
Stempoint Capital
Merck & Co
Takeda Pharmaceutical
Vanguard Group
Empery Asset Management
Ghisallo Capital Management
AJU IB Investment
FMR
Renaissance Technologies
Geode Capital Management
Balyasny Asset Management

View all funds holding Xilio Therapeutics